KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

(By Alex Montero, Grace Sparks, Ashley Kirzinger, Isabelle Valdes, and Liz Hamel for Kaiser Family Foundation Published: Aug 04, 2023)

As a relatively new class of prescription drugs, initially approved to treat type 2 diabetes, have been gaining attention for their use as effective weight loss drugs, the latest KFF Health Tracking Poll finds that nearly half of adults (45%) say they would generally be interested in taking a safe and effective prescription weight loss drug, including nearly six in ten (59%) of those who are currently trying to lose weight and half (51%) of those who are trying to lose less than 10 pounds. About seven in ten adults say they have heard at least “a little” about this new class of weight loss drugs, which include Ozempic, Wegovy and Mounjaro. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org